-
1
-
-
2942724339
-
Activation of epidermal growth factor receptor via CCR3 in bronchial epithelial cells
-
Adachi, T., Cui, C.H., Kanda, A., Kayaba, H., Ohta, K. and Chihara, J. 2004. Activation of epidermal growth factor receptor via CCR3 in bronchial epithelial cells. Biochem. Biophys. Res. Commun., 320:292-296.
-
(2004)
Biochem. Biophys. Res. Commun.
, vol.320
, pp. 292-296
-
-
Adachi, T.1
Cui, C.H.2
Kanda, A.3
Kayaba, H.4
Ohta, K.5
Chihara, J.6
-
2
-
-
33745112984
-
The role of platelet-derived growth factor receptor in eotaxin signaling of eosinophils
-
Adachi, T., Hanaka, S., Yano, T., Yamamura, K., Yoshihara, H., Nagase, H., Chihara, J. and Ohta, K. 2006. The role of platelet-derived growth factor receptor in eotaxin signaling of eosinophils. Int. Arch. Allergy Immunol., 140 Suppl 1:28-34.
-
(2006)
Int. Arch. Allergy Immunol.
, vol.140
, pp. 28-34
-
-
Adachi, T.1
Hanaka, S.2
Yano, T.3
Yamamura, K.4
Yoshihara, H.5
Nagase, H.6
Chihara, J.7
Ohta, K.8
-
3
-
-
0036063077
-
Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate
-
Ault, P., Cortes, J., Koller, C., Kaled, E.S. and Kantarjian, H. 2002. Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate. Leuk. Res., 26:881-884.
-
(2002)
Leuk. Res.
, vol.26
, pp. 881-884
-
-
Ault, P.1
Cortes, J.2
Koller, C.3
Kaled, E.S.4
Kantarjian, H.5
-
4
-
-
33745751781
-
A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophilia
-
Bacher, U., Reiter, A., Haferlach, T., Mueller, L., Schnittger, S., Kern, W. and Schoch, C. 2006. A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophilia. Haematologica, 91:817-820.
-
(2006)
Haematologica
, vol.91
, pp. 817-820
-
-
Bacher, U.1
Reiter, A.2
Haferlach, T.3
Mueller, L.4
Schnittger, S.5
Kern, W.6
Schoch, C.7
-
5
-
-
0002884977
-
-
IARC Press, Lyon, France
-
Bain, B., Pierre, R., Imbert, M., Vardiman, J.W., Brunning, R.D. and Flandrin, G. 2001. Chronic eosinophilic leukaemia and the hypereosinophilic syndrome. IARC Press, Lyon, France.
-
(2001)
Chronic eosinophilic leukaemia and the hypereosinophilic syndrome
-
-
Bain, B.1
Pierre, R.2
Imbert, M.3
Vardiman, J.W.4
Brunning, R.D.5
Flandrin, G.6
-
6
-
-
0034914653
-
The hypereosinophilic syndrome associated with CD4+CD3- helper type 2 (Th2) lymphocytes
-
Bank, I., Amariglio, N., Reshef, A., Hardan, I., Confino, Y., Trau, H., Shtrasburg, S., Langevitz, P., Monselise, Y., Shalit, M. and Rechavi, G. 2001. The hypereosinophilic syndrome associated with CD4+CD3- helper type 2 (Th2) lymphocytes. Leuk. Lymphoma, 42:123-133.
-
(2001)
Leuk. Lymphoma
, vol.42
, pp. 123-133
-
-
Bank, I.1
Amariglio, N.2
Reshef, A.3
Hardan, I.4
Confino, Y.5
Trau, H.6
Shtrasburg, S.7
Langevitz, P.8
Monselise, Y.9
Shalit, M.10
Rechavi, G.11
-
7
-
-
0028069002
-
The chronic myeloid leukaemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group
-
Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H., Sultan, C. and Cox, C. 1994. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br. J. Haematol., 87:746-754.
-
(1994)
Br. J. Haematol.
, vol.87
, pp. 746-754
-
-
Bennett, J.M.1
Catovsky, D.2
Daniel, M.T.3
Flandrin, G.4
Galton, D.A.5
Gralnick, H.6
Sultan, C.7
Cox, C.8
-
8
-
-
0022670147
-
Acute myelomonocytic leukemia type M4 with bone marrow eosinophilia and t(5;16)(q33;q22)
-
Bhambhani, K., Inoue, S., Tyrkus, M. and Gohle, N. 1986. Acute myelomonocytic leukemia type M4 with bone marrow eosinophilia and t(5;16)(q33;q22). Cancer Genet. Cytogenet., 20:187-188.
-
(1986)
Cancer Genet. Cytogenet.
, vol.20
, pp. 187-188
-
-
Bhambhani, K.1
Inoue, S.2
Tyrkus, M.3
Gohle, N.4
-
9
-
-
0022571167
-
Acute eosinophilic leukemia with a translocation (10p+;11q-)
-
Broustet, A., Bernard, P., Dachary, D., David, B., Marit, G., Lacombe, F., Issanchou, A.M. and Reiffers, J. 1986. Acute eosinophilic leukemia with a translocation (10p+;11q-). Cancer Genet. Cytogenet., 21:327-333.
-
(1986)
Cancer Genet. Cytogenet.
, vol.21
, pp. 327-333
-
-
Broustet, A.1
Bernard, P.2
Dachary, D.3
David, B.4
Marit, G.5
Lacombe, F.6
Issanchou, A.M.7
Reiffers, J.8
-
10
-
-
0037217955
-
Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells
-
Buitenhuis, M., Baltus, B., Lammers, J.W., Coffer, P.J. and Koenderman, L. 2003. Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells. Blood, 101:134-142.
-
(2003)
Blood
, vol.101
, pp. 134-142
-
-
Buitenhuis, M.1
Baltus, B.2
Lammers, J.W.3
Coffer, P.J.4
Koenderman, L.5
-
11
-
-
0033104707
-
Clonality of isolated eosinophils in the hypereosinophilic syndrome
-
Chang, H.W., Leong, K.H., Koh, D.R. and Lee, S.H. 1999. Clonality of isolated eosinophils in the hypereosinophilic syndrome. Blood, 93:1651-1657.
-
(1999)
Blood
, vol.93
, pp. 1651-1657
-
-
Chang, H.W.1
Leong, K.H.2
Koh, D.R.3
Lee, S.H.4
-
12
-
-
0016430025
-
The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature
-
Chusid, M.J., Dale, D.C., West, B.C. and Wolff, S.M. 1975. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore), 54:1-27.
-
(1975)
Medicine (Baltimore)
, vol.54
, pp. 1-27
-
-
Chusid, M.J.1
Dale, D.C.2
West, B.C.3
Wolff, S.M.4
-
13
-
-
0027958133
-
Brief report: Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome
-
Cogan, E., Schandene, L., Crusiaux, A., Cochaux, P., Velu, T. and Goldman, M. 1994. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N. Engl. J. Med., 330:535-538.
-
(1994)
N. Engl. J. Med.
, vol.330
, pp. 535-538
-
-
Cogan, E.1
Schandene, L.2
Crusiaux, A.3
Cochaux, P.4
Velu, T.5
Goldman, M.6
-
14
-
-
0344987881
-
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
-
Cools, J., DeAngelo, D.J., Gotlib, J., Stover, E.H., Legare, R.D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J.D., Cross, N.C., Tefferi, A., Malone, J., Alam, R., Schrier, S.L., Schmid, J., Rose, M., Vandenberghe, P., Verhoef, G., Boogaerts, M., Wlodarska, I., Kantarjian, H., Marynen, P., Coutre, S.E., Stone, R. and Gilliland, D.G. 2003a. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N. Engl. J. Med., 348:1201-1214.
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 1201-1214
-
-
Cools, J.1
DeAngelo, D.J.2
Gotlib, J.3
Stover, E.H.4
Legare, R.D.5
Cortes, J.6
Kutok, J.7
Clark, J.8
Galinsky, I.9
Griffin, J.D.10
Cross, N.C.11
Tefferi, A.12
Malone, J.13
Alam, R.14
Schrier, S.L.15
Schmid, J.16
Rose, M.17
Vandenberghe, P.18
Verhoef, G.19
Boogaerts, M.20
Wlodarska, I.21
Kantarjian, H.22
Marynen, P.23
Coutre, S.E.24
Stone, R.25
Gilliland, D.G.26
more..
-
15
-
-
1642324059
-
The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia
-
Cools, J., Quentmeier, H., Huntly, B.J., Marynen, P., Griffin, J.D., Drexler, H.G. and Gilliland, D.G. 2004. The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood, 103:2802-2805.
-
(2004)
Blood
, vol.103
, pp. 2802-2805
-
-
Cools, J.1
Quentmeier, H.2
Huntly, B.J.3
Marynen, P.4
Griffin, J.D.5
Drexler, H.G.6
Gilliland, D.G.7
-
16
-
-
0142119964
-
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease
-
Cools, J., Stover, E.H., Boulton, C.L., Gotlib, J., Legare, R.D., Amaral, S.M., Curley, D.P., Duclos, N., Rowan, R., Kutok, J.L., Lee, B.H., Williams, I.R., Coutre, S.E., Stone, R.M., DeAngelo, D.J., Marynen, P., Manley, P.W., Meyer, T., Fabbro, D., Neuberg, D., Weisberg, E., Griffin, J.D. and Gilliland, D.G. 2003b. PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease. Cancer Cell, 3:459-469.
-
(2003)
Cancer Cell
, vol.3
, pp. 459-469
-
-
Cools, J.1
Stover, E.H.2
Boulton, C.L.3
Gotlib, J.4
Legare, R.D.5
Amaral, S.M.6
Curley, D.P.7
Duclos, N.8
Rowan, R.9
Kutok, J.L.10
Lee, B.H.11
Williams, I.R.12
Coutre, S.E.13
Stone, R.M.14
DeAngelo, D.J.15
Marynen, P.16
Manley, P.W.17
Meyer, T.18
Fabbro, D.19
Neuberg, D.20
Weisberg, E.21
Griffin, J.D.22
Gilliland, D.G.23
more..
-
17
-
-
10744228476
-
Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome
-
Cortes, J., Ault, P., Koller, C., Thomas, D., Ferrajoli, A., Wierda, W., Rios, M.B., Letvak, L., Kaled, E.S. and Kantarjian, H. 2003. Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood, 101:4714-4716.
-
(2003)
Blood
, vol.101
, pp. 4714-4716
-
-
Cortes, J.1
Ault, P.2
Koller, C.3
Thomas, D.4
Ferrajoli, A.5
Wierda, W.6
Rios, M.B.7
Letvak, L.8
Kaled, E.S.9
Kantarjian, H.10
-
18
-
-
0030044360
-
Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
-
Daub, H., Weiss, F.U., Wallasch, C. and Ullrich, A. 1996. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature, 379:557-560.
-
(1996)
Nature
, vol.379
, pp. 557-560
-
-
Daub, H.1
Weiss, F.U.2
Wallasch, C.3
Ullrich, A.4
-
19
-
-
0031718359
-
Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family
-
de Groot, R.P., Coffer, P.J. and Koenderman, L. 1998. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal, 10:619-628.
-
(1998)
Cell Signal
, vol.10
, pp. 619-628
-
-
de Groot, R.P.1
Coffer, P.J.2
Koenderman, L.3
-
20
-
-
0041466445
-
Specific targeted therapy of chronic myelogenous leukemia with imatinib
-
Deininger, M.W. and Druker, B.J. 2003. Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacol. Rev., 55:401-423.
-
(2003)
Pharmacol. Rev.
, vol.55
, pp. 401-423
-
-
Deininger, M.W.1
Druker, B.J.2
-
21
-
-
0025036906
-
Eosinophilia in transgenic mice expressing interleukin 5
-
Dent, L.A., Strath, M., Mellor, A.L. and Sanderson, C.J. 1990. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med., 172:1425-1431.
-
(1990)
J. Exp. Med.
, vol.172
, pp. 1425-1431
-
-
Dent, L.A.1
Strath, M.2
Mellor, A.L.3
Sanderson, C.J.4
-
22
-
-
0029947186
-
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
-
Druker, B.J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G.M., Fanning, S., Zimmermann, J. and Lydon, N.B. 1996. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat. Med., 2:561-566.
-
(1996)
Nat. Med.
, vol.2
, pp. 561-566
-
-
Druker, B.J.1
Tamura, S.2
Buchdunger, E.3
Ohno, S.4
Segal, G.M.5
Fanning, S.6
Zimmermann, J.7
Lydon, N.B.8
-
23
-
-
9144221389
-
Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes
-
Garrett, J.K., Jameson, S.C., Thomson, B., Collins, M.H., Wagoner, L.E., Freese, D.K., Beck, L.A., Boyce, J.A., Filipovich, A.H., Villanueva, J.M., Sutton, S.A., Assa'ad, A.H. and Rothenberg, M.E. 2004. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J. Allergy Clin. Immunol., 113:115-119.
-
(2004)
J. Allergy Clin. Immunol.
, vol.113
, pp. 115-119
-
-
Garrett, J.K.1
Jameson, S.C.2
Thomson, B.3
Collins, M.H.4
Wagoner, L.E.5
Freese, D.K.6
Beck, L.A.7
Boyce, J.A.8
Filipovich, A.H.9
Villanueva, J.M.10
Sutton, S.A.11
Assa'ad, A.H.12
Rothenberg, M.E.13
-
24
-
-
4043141422
-
FIP1L1-PDGFRalpha in hypereosinophilic syndrome and mastocytosis
-
Gilliland, G., Cools, J., Stover, E.H., Wlodarska, I. and Marynen, P. 2004. FIP1L1-PDGFRalpha in hypereosinophilic syndrome and mastocytosis. Hematol. J., 5 Suppl 3:S133-137.
-
(2004)
Hematol. J.
, vol.5
, pp. S133-S137
-
-
Gilliland, G.1
Cools, J.2
Stover, E.H.3
Wlodarska, I.4
Marynen, P.5
-
25
-
-
0037018763
-
Treatment of hypereosinophilic syndrome with imatinib mesilate
-
Gleich, G.J., Leiferman, K.M., Pardanani, A., Tefferi, A. and Butterfield, J.H. 2002. Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet., 359:1577-1578.
-
(2002)
Lancet.
, vol.359
, pp. 1577-1578
-
-
Gleich, G.J.1
Leiferman, K.M.2
Pardanani, A.3
Tefferi, A.4
Butterfield, J.H.5
-
26
-
-
0038574498
-
Eosinophilic variant of chronic myeloid leukemia with vascular complications
-
Gotlib, V., Darji, J., Bloomfield, K., Chadburn, A., Patel, A. and Braunschweig, I. 2003. Eosinophilic variant of chronic myeloid leukemia with vascular complications. Leuk. Lymphoma, 44:1609-1613.
-
(2003)
Leuk. Lymphoma
, vol.44
, pp. 1609-1613
-
-
Gotlib, V.1
Darji, J.2
Bloomfield, K.3
Chadburn, A.4
Patel, A.5
Braunschweig, I.6
-
27
-
-
0037596569
-
Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome
-
Griffin, J.H., Leung, J., Bruner, R.J., Caligiuri, M.A. and Briesewitz, R. 2003. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc. Natl. Acad. Sci. U.S.A., 100:7830-7835.
-
(2003)
Proc. Natl. Acad. Sci. U.S.A.
, vol.100
, pp. 7830-7835
-
-
Griffin, J.H.1
Leung, J.2
Bruner, R.J.3
Caligiuri, M.A.4
Briesewitz, R.5
-
28
-
-
0027771752
-
Hypereosinophilic syndrome in childhood: Trisomy 8 and transformation to mixed acute leukaemia
-
Guitard, A.M., Horschowski, N., Mozziconacci, M.J., Michel, G., George, F., Capodano, A.M. and Perrimond, H. 1994. Hypereosinophilic syndrome in childhood: trisomy 8 and transformation to mixed acute leukaemia. Nouv. Rev. Fr. Hematol., 35:555-559.
-
(1994)
Nouv. Rev. Fr. Hematol.
, vol.35
, pp. 555-559
-
-
Guitard, A.M.1
Horschowski, N.2
Mozziconacci, M.J.3
Michel, G.4
George, F.5
Capodano, A.M.6
Perrimond, H.7
-
29
-
-
0014299959
-
The hypereosinophilic syndromes
-
Hardy, W.R. and Anderson, R.E. 1968. The hypereosinophilic syndromes. Ann. Intern. Med., 68:1220-1229.
-
(1968)
Ann. Intern. Med.
, vol.68
, pp. 1220-1229
-
-
Hardy, W.R.1
Anderson, R.E.2
-
30
-
-
0023811073
-
Acute myelogenous leukemia with eosinophilic differentiation and trisomy-1
-
Harrington, D.S., Peterson, C., Ness, M., Sanger, W., Smith, D.M. and Vaughan, W. 1988. Acute myelogenous leukemia with eosinophilic differentiation and trisomy-1. Am. J. Clin. Pathol., 90:464-469.
-
(1988)
Am. J. Clin. Pathol.
, vol.90
, pp. 464-469
-
-
Harrington, D.S.1
Peterson, C.2
Ness, M.3
Sanger, W.4
Smith, D.M.5
Vaughan, W.6
-
31
-
-
33646533541
-
The results of imatinib therapy for patients with primary eosinophilic disorders
-
Helbig, G., Stella-Holowiecka, B., Grosicki, S., Bober, G., Krawczyk, M., Wojnar, J., Reiter, A., Hochhaus, A. and Holowiecki, J. 2006. The results of imatinib therapy for patients with primary eosinophilic disorders. Eur. J. Haematol., 76:535-536.
-
(2006)
Eur. J. Haematol.
, vol.76
, pp. 535-536
-
-
Helbig, G.1
Stella-Holowiecka, B.2
Grosicki, S.3
Bober, G.4
Krawczyk, M.5
Wojnar, J.6
Reiter, A.7
Hochhaus, A.8
Holowiecki, J.9
-
32
-
-
0032555202
-
Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells
-
Herrlich, A., Daub, H., Knebel, A., Herrlich, P., Ullrich, A., Schultz, G. and Gudermann, T. 1998. Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. Proc. Natl. Acad. Sci. U.S.A., 95:8985-8990.
-
(1998)
Proc. Natl. Acad. Sci. U.S.A.
, vol.95
, pp. 8985-8990
-
-
Herrlich, A.1
Daub, H.2
Knebel, A.3
Herrlich, P.4
Ullrich, A.5
Schultz, G.6
Gudermann, T.7
-
33
-
-
2942594298
-
Juxtamembrane autoinhibition in receptor tyrosine kinases
-
Hubbard, S.R. 2004. Juxtamembrane autoinhibition in receptor tyrosine kinases. Nat. Rev. Mol. Cell Biol., 5:464-471.
-
(2004)
Nat. Rev. Mol. Cell Biol.
, vol.5
, pp. 464-471
-
-
Hubbard, S.R.1
-
34
-
-
33646900800
-
Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report
-
The Hypereosinophilic Syndromes Working G
-
Klion, A.D., Bochner, B.S., Gleich, G.J., Nutman, T.B., Rothenberg, M.E., Simon, H.U., Wechsler, M.E., Weller, P.F. and The Hypereosinophilic Syndromes Working, G. 2006. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J. Allergy Clin. Immunol., 117:1292-1302.
-
(2006)
J. Allergy Clin. Immunol.
, vol.117
, pp. 1292-1302
-
-
Klion, A.D.1
Bochner, B.S.2
Gleich, G.J.3
Nutman, T.B.4
Rothenberg, M.E.5
Simon, H.U.6
Wechsler, M.E.7
Weller, P.F.8
-
35
-
-
1842579577
-
Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome
-
Klion, A.D., Law, M.A., Noel, P., Kim, Y.J., Haverty, T.P. and Nutman, T.B. 2004a. Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. Blood, 103:2939-2941.
-
(2004)
Blood
, vol.103
, pp. 2939-2941
-
-
Klion, A.D.1
Law, M.A.2
Noel, P.3
Kim, Y.J.4
Haverty, T.P.5
Nutman, T.B.6
-
36
-
-
0038792233
-
Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness
-
Klion, A.D., Noel, P., Akin, C., Law, M.A., Gilliland, D.G., Cools, J., Metcalfe, D.D. and Nutman, T.B. 2003. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood, 101:4660-4666.
-
(2003)
Blood
, vol.101
, pp. 4660-4666
-
-
Klion, A.D.1
Noel, P.2
Akin, C.3
Law, M.A.4
Gilliland, D.G.5
Cools, J.6
Metcalfe, D.D.7
Nutman, T.B.8
-
37
-
-
0942276859
-
Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome
-
Klion, A.D., Robyn, J., Akin, C., Noel, P., Brown, M., Law, M., Metcalfe, D.D., Dunbar, C. and Nutman, T.B. 2004b. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood, 103:473-478.
-
(2004)
Blood
, vol.103
, pp. 473-478
-
-
Klion, A.D.1
Robyn, J.2
Akin, C.3
Noel, P.4
Brown, M.5
Law, M.6
Metcalfe, D.D.7
Dunbar, C.8
Nutman, T.B.9
-
38
-
-
20344407088
-
The hypereosinophilic syndrome: Fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases
-
La Starza, R., Specchia, G., Cuneo, A., Beacci, D., Nozzoli, C., Luciano, L., Aventin, A., Sambani, C., Testoni, N., Foppoli, M., Invernizzi, R., Marynen, P., Martelli, M.F. and Mecucci, C. 2005. The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases. Haematologica, 90:596-601.
-
(2005)
Haematologica
, vol.90
, pp. 596-601
-
-
La Starza, R.1
Specchia, G.2
Cuneo, A.3
Beacci, D.4
Nozzoli, C.5
Luciano, L.6
Aventin, A.7
Sambani, C.8
Testoni, N.9
Foppoli, M.10
Invernizzi, R.11
Marynen, P.12
Martelli, M.F.13
Mecucci, C.14
-
39
-
-
0029826814
-
Synthesis of type 1 (IFN gamma) and type 2 (IL-4, IL-5, and IL-10) cytokines by human eosinophils
-
Lamkhioued, B., Gounni, A.S., Aldebert, D., Delaporte, E., Prin, L., Capron, A. and Capron, M. 1996. Synthesis of type 1 (IFN gamma) and type 2 (IL-4, IL-5, and IL-10) cytokines by human eosinophils. Ann. NY Acad. Sci., 796:203-208.
-
(1996)
Ann. NY Acad. Sci.
, vol.796
, pp. 203-208
-
-
Lamkhioued, B.1
Gounni, A.S.2
Aldebert, D.3
Delaporte, E.4
Prin, L.5
Capron, A.6
Capron, M.7
-
40
-
-
0021930188
-
Metallothionein gene cluster is split by chromosome 16 rearrangements in myelomonocytic leukaemia
-
Le Beau, M.M., Diaz, M.O., Karin, M. and Rowley, J.D. 1985. Metallothionein gene cluster is split by chromosome 16 rearrangements in myelomonocytic leukaemia. Nature, 313:709-711.
-
(1985)
Nature
, vol.313
, pp. 709-711
-
-
Le Beau, M.M.1
Diaz, M.O.2
Karin, M.3
Rowley, J.D.4
-
41
-
-
14844288048
-
The activation of JAK/STAT signal pathway in hypereosinophilic syndrome and the patients therapeutic response to imatinib
-
Li, B., Zhang, G.S., Dai, C.W. and Pei, M.F. 2005. [The activation of JAK/STAT signal pathway in hypereosinophilic syndrome and the patients therapeutic response to imatinib]. Zhonghua Yi Xue Za Zhi, 85:448-452.
-
(2005)
Zhonghua Yi Xue Za Zhi
, vol.85
, pp. 448-452
-
-
Li, B.1
Zhang, G.S.2
Dai, C.W.3
Pei, M.F.4
-
42
-
-
0035282909
-
Interleukin 3 and granulocyte-macrophage colonystimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL
-
Li, S., Gillessen, S., Tomasson, M.H., Dranoff, G., Gilliland, D.G. and Van Etten, R.A. 2001. Interleukin 3 and granulocyte-macrophage colonystimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL. Blood, 97:1442-1450.
-
(2001)
Blood
, vol.97
, pp. 1442-1450
-
-
Li, S.1
Gillessen, S.2
Tomasson, M.H.3
Dranoff, G.4
Gilliland, D.G.5
Van Etten, R.A.6
-
43
-
-
33747203008
-
Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant
-
Lierman, E., Folens, C., Stover, E.H., Mentens, N., Van Miegroet, H., Scheers, W., Boogaerts, M., Vandenberghe, P., Marynen, P. and Cools, J. 2006. Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant. Blood, 108:1374-1376.
-
(2006)
Blood
, vol.108
, pp. 1374-1376
-
-
Lierman, E.1
Folens, C.2
Stover, E.H.3
Mentens, N.4
Van Miegroet, H.5
Scheers, W.6
Boogaerts, M.7
Vandenberghe, P.8
Marynen, P.9
Cools, J.10
-
44
-
-
0029020637
-
Refractory cytopenia with t(1;7),+8 abnormality and dysplastic eosinophils showing intranuclear Charcot-Leyden crystals: A fluorescence in situ hybridization study
-
Ma, S.K., Wong, K.F., Chan, J.K. and Kwong, Y.L. 1995. Refractory cytopenia with t(1;7),+8 abnormality and dysplastic eosinophils showing intranuclear Charcot-Leyden crystals: a fluorescence in situ hybridization study. Br. J. Haematol., 90:216-218.
-
(1995)
Br. J. Haematol.
, vol.90
, pp. 216-218
-
-
Ma, S.K.1
Wong, K.F.2
Chan, J.K.3
Kwong, Y.L.4
-
45
-
-
0029031712
-
Cytogenetic and clinical correlates in AMLpatients with abnormalities of chromosome 16
-
Marlton, P., Keating, M., Kantarjian, H., Pierce, S., O'Brien, S., Freireich, E.J. and Estey, E. 1995. Cytogenetic and clinical correlates in AMLpatients with abnormalities of chromosome 16. Leukemia, 9:965-971.
-
(1995)
Leukemia
, vol.9
, pp. 965-971
-
-
Marlton, P.1
Keating, M.2
Kantarjian, H.3
Pierce, S.4
O'Brien, S.5
Freireich, E.J.6
Estey, E.7
-
46
-
-
0029131922
-
Steroid-responsive pulmonary disorders associated with myelodysplastic syndromes with der(1q;7p) chromosomal abnormality
-
Matsushima, T., Murakami, H., Kim, K., Uchiumi, H., Murata, N., Tamura, J., Sawamura, M., Karasawa, M., Naruse, T. and Tsuchiya, J. 1995. Steroid-responsive pulmonary disorders associated with myelodysplastic syndromes with der(1q;7p) chromosomal abnormality. Am. J. Hematol., 50:110-115.
-
(1995)
Am. J. Hematol.
, vol.50
, pp. 110-115
-
-
Matsushima, T.1
Murakami, H.2
Kim, K.3
Uchiumi, H.4
Murata, N.5
Tamura, J.6
Sawamura, M.7
Karasawa, M.8
Naruse, T.9
Tsuchiya, J.10
-
47
-
-
0021842599
-
Acute nonlymphoblastic leukemia with bone marrow eosinophilia and structural anomaly of chromosome 16
-
Mecucci, C., Bosly, A., Michaux, J.L., Broeckaert-Van Orshoven, A. and Van den Berghe, H. 1985. Acute nonlymphoblastic leukemia with bone marrow eosinophilia and structural anomaly of chromosome 16. Cancer Genet. Cytogenet., 17:359-363.
-
(1985)
Cancer Genet. Cytogenet.
, vol.17
, pp. 359-363
-
-
Mecucci, C.1
Bosly, A.2
Michaux, J.L.3
Broeckaert-Van Orshoven, A.4
Van den Berghe, H.5
-
48
-
-
0025093035
-
Hypereosinophilic syndrome with evolution to myeloproliferative disorder: Temporal relationship to loss of Y chromosome and c-N-ras activation
-
Needleman, S.W., Mane, S.M., Gutheil, J.C., Kapil, V., Heyman, M.R. and Testa, J.R. 1990. Hypereosinophilic syndrome with evolution to myeloproliferative disorder: temporal relationship to loss of Y chromosome and c-N-ras activation. Hematol. Pathol., 4:149-155.
-
(1990)
Hematol. Pathol.
, vol.4
, pp. 149-155
-
-
Needleman, S.W.1
Mane, S.M.2
Gutheil, J.C.3
Kapil, V.4
Heyman, M.R.5
Testa, J.R.6
-
49
-
-
33746473457
-
Chronic eosinophilic leukaemia with FIP1L1-PDGFRA fusion and T674I mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy
-
Ohnishi, H., Kandabashi, K., Maeda, Y., Kawamura, M. and Watanabe, T. 2006. Chronic eosinophilic leukaemia with FIP1L1-PDGFRA fusion and T674I mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy. Br. J. Haematol.
-
(2006)
Br. J. Haematol.
-
-
Ohnishi, H.1
Kandabashi, K.2
Maeda, Y.3
Kawamura, M.4
Watanabe, T.5
-
50
-
-
0024356310
-
Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome
-
Owen, W.F., Rothenberg, M.E., Petersen, J., Weller, P.F., Silberstein, D.,Sheffer, A.L., Stevens, R.L., Soberman, R.J. and Austen, K.F. 1989. Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J. Exp. Med., 170:343-348.
-
(1989)
J. Exp. Med.
, vol.170
, pp. 343-348
-
-
Owen, W.F.1
Rothenberg, M.E.2
Petersen, J.3
Weller, P.F.4
Silberstein, D.5
Sheffer, A.L.6
Stevens, R.L.7
Soberman, R.J.8
Austen, K.F.9
-
51
-
-
8644263305
-
FIP1L1-PDGFRA fusion: Prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia
-
Pardanani, A., Brockman, S.R., Paternoster, S.F., Flynn, H.C., Ketterling, R.P., Lasho, T.L., Ho, C.L., Li, C.Y., Dewald, G.W. and Tefferi, A. 2004. FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood, 104:3038-3045.
-
(2004)
Blood
, vol.104
, pp. 3038-3045
-
-
Pardanani, A.1
Brockman, S.R.2
Paternoster, S.F.3
Flynn, H.C.4
Ketterling, R.P.5
Lasho, T.L.6
Ho, C.L.7
Li, C.Y.8
Dewald, G.W.9
Tefferi, A.10
-
52
-
-
10744228486
-
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy
-
Pardanani, A., Ketterling, R.P., Brockman, S.R., Flynn, H.C., Paternoster, S.F., Shearer, B.M., Reeder, T.L., Li, C.Y., Cross, N.C., Cools, J., Gilliland, D.G., Dewald, G.W. and Tefferi, A. 2003a. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood, 102:3093-3096.
-
(2003)
Blood
, vol.102
, pp. 3093-3096
-
-
Pardanani, A.1
Ketterling, R.P.2
Brockman, S.R.3
Flynn, H.C.4
Paternoster, S.F.5
Shearer, B.M.6
Reeder, T.L.7
Li, C.Y.8
Cross, N.C.9
Cools, J.10
Gilliland, D.G.11
Dewald, G.W.12
Tefferi, A.13
-
53
-
-
33646532818
-
FIP1L1-PDGFRA in eosinophilic disorders: Prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature
-
Pardanani, A., Ketterling, R.P., Li, C.Y., Patnaik, M.M., Wolanskyj, A.P., Elliott, M.A., Camoriano, J.K., Butterfield, J.H., Dewald, G.W. and Tefferi, A. 2006. FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. Leuk. Res., 30:965-970.
-
(2006)
Leuk. Res.
, vol.30
, pp. 965-970
-
-
Pardanani, A.1
Ketterling, R.P.2
Li, C.Y.3
Patnaik, M.M.4
Wolanskyj, A.P.5
Elliott, M.A.6
Camoriano, J.K.7
Butterfield, J.H.8
Dewald, G.W.9
Tefferi, A.10
-
54
-
-
0038386031
-
Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders
-
Pardanani, A., Reeder, T., Porrata, L.F., Li, C.Y., Tazelaar, H.D., Baxter, E.J., Witzig, T.E., Cross, N.C. and Tefferi, A. 2003b. Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood, 101:3391-3397.
-
(2003)
Blood
, vol.101
, pp. 3391-3397
-
-
Pardanani, A.1
Reeder, T.2
Porrata, L.F.3
Li, C.Y.4
Tazelaar, H.D.5
Baxter, E.J.6
Witzig, T.E.7
Cross, N.C.8
Tefferi, A.9
-
55
-
-
1342279452
-
Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders
-
Pardanani, A. and Tefferi, A. 2004. Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders. Leuk. Res., 28 Suppl 1:S47-52.
-
(2004)
Leuk. Res.
, vol.28
, pp. S47-S52
-
-
Pardanani, A.1
Tefferi, A.2
-
56
-
-
0346816643
-
Use of an antiinterleukin- 5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis
-
Plotz, S.G., Simon, H.U., Darsow, U., Simon, D., Vassina, E., Yousefi, S., Hein, R., Smith, T., Behrendt, H. and Ring, J. 2003. Use of an antiinterleukin- 5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N. Engl. J. Med., 349:2334-2339.
-
(2003)
N. Engl. J. Med.
, vol.349
, pp. 2334-2339
-
-
Plotz, S.G.1
Simon, H.U.2
Darsow, U.3
Simon, D.4
Vassina, E.5
Yousefi, S.6
Hein, R.7
Smith, T.8
Behrendt, H.9
Ring, J.10
-
57
-
-
0028932040
-
Alpha-Interferon and hypereosinophilic syndrome with trisomy 8: Karyotypic remission
-
Quiquandon, I., Claisse, J.F., Capiod, J.C., Delobel, J. and Prin, L. 1995. alpha-Interferon and hypereosinophilic syndrome with trisomy 8: karyotypic remission. Blood, 85:2284-2285.
-
(1995)
Blood
, vol.85
, pp. 2284-2285
-
-
Quiquandon, I.1
Claisse, J.F.2
Capiod, J.C.3
Delobel, J.4
Prin, L.5
-
58
-
-
0023568002
-
Tlymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome
-
Raghavachar, A., Fleischer, S., Frickhofen, N., Heimpel, H. and Fleischer, B. 1987. Tlymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome. J. Immunol., 139:3753-3758.
-
(1987)
J. Immunol.
, vol.139
, pp. 3753-3758
-
-
Raghavachar, A.1
Fleischer, S.2
Frickhofen, N.3
Heimpel, H.4
Fleischer, B.5
-
59
-
-
20144389913
-
The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2
-
Reiter, A., Walz, C., Watmore, A., Schoch, C., Blau, I., Schlegelberger, B., Berger, U., Telford, N., Aruliah, S., Yin, J.A., Vanstraelen, D., Barker, H.F., Taylor, P.C., O'Driscoll, A., Benedetti, F., Rudolph, C., Kolb, H.J., Hochhaus, A., Hehlmann, R., Chase, A. and Cross, N.C. 2005. The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2. Cancer Res., 65:2662-2667.
-
(2005)
Cancer Res.
, vol.65
, pp. 2662-2667
-
-
Reiter, A.1
Walz, C.2
Watmore, A.3
Schoch, C.4
Blau, I.5
Schlegelberger, B.6
Berger, U.7
Telford, N.8
Aruliah, S.9
Yin, J.A.10
Vanstraelen, D.11
Barker, H.F.12
Taylor, P.C.13
O'Driscoll, A.14
Benedetti, F.15
Rudolph, C.16
Kolb, H.J.17
Hochhaus, A.18
Hehlmann, R.19
Chase, A.20
Cross, N.C.21
more..
-
60
-
-
33644868101
-
Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA-positive hypereosinophilic syndrome
-
Robyn, J., Lemery, S., McCoy, J.P., Kubofcik, J., Kim, Y.J., Pack, S., Nutman, T.B., Dunbar, C. and Klion, A.D. 2006. Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA-positive hypereosinophilic syndrome. Br. J. Haematol., 132:286-292.
-
(2006)
Br. J. Haematol.
, vol.132
, pp. 286-292
-
-
Robyn, J.1
Lemery, S.2
McCoy, J.P.3
Kubofcik, J.4
Kim, Y.J.5
Pack, S.6
Nutman, T.B.7
Dunbar, C.8
Klion, A.D.9
-
61
-
-
20844452877
-
Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics
-
Roche-Lestienne, C., Lepers, S., Soenen-Cornu, V., Kahn, J.E., Lai, J.L., Hachulla, E., Drupt, F., Demarty, A.L., Roumier, A.S., Gardembas, M., Dib, M., Philippe, N., Cambier, N., Barete, S., Libersa, C., Bletry, O., Hatron, P.Y., Quesnel, B., Rose, C., Maloum, K., Blanchet, O., Fenaux, P., Prin, L. and Preudhomme, C. 2005. Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia, 19:792-798.
-
(2005)
Leukemia
, vol.19
, pp. 792-798
-
-
Roche-Lestienne, C.1
Lepers, S.2
Soenen-Cornu, V.3
Kahn, J.E.4
Lai, J.L.5
Hachulla, E.6
Drupt, F.7
Demarty, A.L.8
Roumier, A.S.9
Gardembas, M.10
Dib, M.11
Philippe, N.12
Cambier, N.13
Barete, S.14
Libersa, C.15
Bletry, O.16
Hatron, P.Y.17
Quesnel, B.18
Rose, C.19
Maloum, K.20
Blanchet, O.21
Fenaux, P.22
Prin, L.23
Preudhomme, C.24
more..
-
62
-
-
3042742422
-
Recent advances in pathogenesis and management of hypereosinophilic syndromes
-
Roufosse, F., Cogan, E. and Goldman, M. 2004. Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy, 59:673-689.
-
(2004)
Allergy
, vol.59
, pp. 673-689
-
-
Roufosse, F.1
Cogan, E.2
Goldman, M.3
-
63
-
-
0035823530
-
Case report: Rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate
-
Schaller, J.L. and Burkland, G.A. 2001. Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate. Med. Gen. Med., 3:9.
-
(2001)
Med. Gen. Med.
, vol.3
, pp. 9
-
-
Schaller, J.L.1
Burkland, G.A.2
-
64
-
-
21344433296
-
Chromosome Banding Analysis, FISH and RT-PCR Performed in Parallel in Hypereosinophilic Syndrome Establishes the Diagnosis of Chronic Eosinophilic Leukemia in 22% of Cases: A Study on 40 Patients
-
Schoch, C., Reiter, A., Bursch, S., Schnittger, S., Hiddemann, W., Kern, W. and Haferlach, T. 2004. Chromosome Banding Analysis, FISH and RT-PCR Performed in Parallel in Hypereosinophilic Syndrome Establishes the Diagnosis of Chronic Eosinophilic Leukemia in 22% of Cases: A Study on 40 Patients. Blood, 104:2444.
-
(2004)
Blood
, vol.104
, pp. 2444
-
-
Schoch, C.1
Reiter, A.2
Bursch, S.3
Schnittger, S.4
Hiddemann, W.5
Kern, W.6
Haferlach, T.7
-
65
-
-
33646152550
-
Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia
-
Score, J., Curtis, C., Waghorn, K., Stalder, M., Jotterand, M., Grand, F.H. and Cross, N.C. 2006. Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia. Leukemia, 20:827-832.
-
(2006)
Leukemia
, vol.20
, pp. 827-832
-
-
Score, J.1
Curtis, C.2
Waghorn, K.3
Stalder, M.4
Jotterand, M.5
Grand, F.H.6
Cross, N.C.7
-
66
-
-
0344809973
-
Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia
-
Simon, H.U., Plotz, S.G., Dummer, R. and Blaser, K. 1999. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N. Engl. J. Med., 341:1112-1120.
-
(1999)
N. Engl. J. Med.
, vol.341
, pp. 1112-1120
-
-
Simon, H.U.1
Plotz, S.G.2
Dummer, R.3
Blaser, K.4
-
67
-
-
2442697890
-
Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses
-
Smith, K.J., Jacobson, E., Hamza, S. and Skelton, H. 2004. Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses. Arch. Dermatol., 140:584-588.
-
(2004)
Arch. Dermatol.
, vol.140
, pp. 584-588
-
-
Smith, K.J.1
Jacobson, E.2
Hamza, S.3
Skelton, H.4
-
68
-
-
0023165265
-
A case of monosomy-7 eosinophilic leukemia and neurofibromatosis, terminated with disseminated cryptococcosis
-
Song, H.S. and Park, S.K. 1987. A case of monosomy-7 eosinophilic leukemia and neurofibromatosis, terminated with disseminated cryptococcosis. Korean J. Intern. Med., 2:131-134.
-
(1987)
Korean J. Intern. Med.
, vol.2
, pp. 131-134
-
-
Song, H.S.1
Park, S.K.2
-
69
-
-
33744484267
-
Activation of FIP1L1-PDGFRalpha requires disruption of the juxtamembrane domain of PDGFRalpha and is FIP1L1-independent
-
Stover, E.H., Chen, J., Folens, C., Lee, B.H., Mentens, N., Marynen, P., Williams, I.R., Gilliland, D.G. and Cools, J. 2006. Activation of FIP1L1-PDGFRalpha requires disruption of the juxtamembrane domain of PDGFRalpha and is FIP1L1-independent. Proc. Natl. Acad. Sci. U.S.A, 103:8078-8083.
-
(2006)
Proc. Natl. Acad. Sci. U.S.A
, vol.103
, pp. 8078-8083
-
-
Stover, E.H.1
Chen, J.2
Folens, C.3
Lee, B.H.4
Mentens, N.5
Marynen, P.6
Williams, I.R.7
Gilliland, D.G.8
Cools, J.9
-
70
-
-
27144551665
-
-
Stover, E.H., Chen, J., Lee, B.H., Cools, J., McDowell, E., Adelsperger, J., Cullen, D., Coburn, A., Moore, S.A., Okabe, R., Fabbro, D., Manley, P.W., Griffin, J.D. and Gilliland, D.G. 2005. The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFR{beta} and FIP1L1-PDGFR{alpha} in vitro and in vivo. Blood.
-
(2005)
The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFR{beta} and FIP1L1-PDGFR{alpha} in vitro and in vivo Blood
-
-
Stover, E.H.1
Chen, J.2
Lee, B.H.3
Cools, J.4
McDowell, E.5
Adelsperger, J.6
Cullen, D.7
Coburn, A.8
Moore, S.A.9
Okabe, R.10
Fabbro, D.11
Manley, P.W.12
Griffin, J.D.13
Gilliland, D.G.14
-
71
-
-
0021329244
-
8;21 translocation in acute granulocytic leukaemia: Cytological, cytochemical and clinical features
-
Swirsky, D.M., Li, Y.S., Matthews, J.G., Flemans, R.J., Rees, J.K. and Hayhoe, F.G. 1984. 8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical features. Br. J. Haematol., 56:199-213.
-
(1984)
Br. J. Haematol.
, vol.56
, pp. 199-213
-
-
Swirsky, D.M.1
Li, Y.S.2
Matthews, J.G.3
Flemans, R.J.4
Rees, J.K.5
Hayhoe, F.G.6
-
72
-
-
3242742988
-
FIP1L1-PDGFRA and c-kit D816V mutationbased clonality studies in systemic mast cell disease associated with eosinophilia
-
Tefferi, A., Lasho, T.L., Brockman, S.R., Elliott, M.A., Dispenzieri, A. and Pardanani, A. 2004. FIP1L1-PDGFRA and c-kit D816V mutationbased clonality studies in systemic mast cell disease associated with eosinophilia. Haematologica, 89:871-873.
-
(2004)
Haematologica
, vol.89
, pp. 871-873
-
-
Tefferi, A.1
Lasho, T.L.2
Brockman, S.R.3
Elliott, M.A.4
Dispenzieri, A.5
Pardanani, A.6
-
73
-
-
33646245681
-
Eosinophilia: Secondary, clonal and idiopathic
-
Tefferi, A., Patnaik, M.M. and Pardanani, A. 2006. Eosinophilia: secondary, clonal and idiopathic. Br. J. Haematol., 133:468-492.
-
(2006)
Br. J. Haematol.
, vol.133
, pp. 468-492
-
-
Tefferi, A.1
Patnaik, M.M.2
Pardanani, A.3
-
74
-
-
3042678647
-
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias
-
Vandenberghe, P., Wlodarska, I., Michaux, L., Zachee, P., Boogaerts, M., Vanstraelen, D., Herregods, M.C., Van Hoof, A., Selleslag, D., Roufosse, F., Maerevoet, M., Verhoef, G., Cools, J., Gilliland, D.G., Hagemeijer, A. and Marynen, P. 2004. Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Leukemia, 18:734-742.
-
(2004)
Leukemia
, vol.18
, pp. 734-742
-
-
Vandenberghe, P.1
Wlodarska, I.2
Michaux, L.3
Zachee, P.4
Boogaerts, M.5
Vanstraelen, D.6
Herregods, M.C.7
Van Hoof, A.8
Selleslag, D.9
Roufosse, F.10
Maerevoet, M.11
Verhoef, G.12
Cools, J.13
Gilliland, D.G.14
Hagemeijer, A.15
Marynen, P.16
-
75
-
-
33749983643
-
Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cells
-
Verstovsek, S., Giles, F.J., Quintas-Cardama, A., Manshouri, T., Huynh, L., Manley, P., Cortes, J., Tefferi, A. and Kantarjian, H. 2006. Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cells. Leuk. Res.
-
(2006)
Leuk. Res.
-
-
Verstovsek, S.1
Giles, F.J.2
Quintas-Cardama, A.3
Manshouri, T.4
Huynh, L.5
Manley, P.6
Cortes, J.7
Tefferi, A.8
Kantarjian, H.9
-
76
-
-
33745059630
-
The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib)
-
author reply 4972
-
von Bubnoff, N., Gorantla, S.P., Thone, S., Peschel, C. and Duyster, J. 2006. The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib). Blood, 107:4970-4971; author reply 4972.
-
(2006)
Blood
, vol.107
, pp. 4970-4971
-
-
von Bubnoff, N.1
Gorantla, S.P.2
Thone, S.3
Peschel, C.4
Duyster, J.5
-
77
-
-
0017626122
-
Ph1-negative eosinophilic leukaemia with trisomy 8. Case report and review of cytogenetic studies
-
Weinfeld, A., Westin, J. and Swolin, B. 1977. Ph1-negative eosinophilic leukaemia with trisomy 8. Case report and review of cytogenetic studies. Scand. J. Haematol. 18:413-420.
-
(1977)
Scand. J. Haematol.
, vol.18
, pp. 413-420
-
-
Weinfeld, A.1
Westin, J.2
Swolin, B.3
-
78
-
-
33646228323
-
The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease
-
Yamada, Y., Rothenberg, M.E., Lee, A.W., Akei, H.S., Brandt, E.B., Williams, D.A. and Cancelas, J.A. 2006. The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease. Blood, 107:4071-4079.
-
(2006)
Blood
, vol.107
, pp. 4071-4079
-
-
Yamada, Y.1
Rothenberg, M.E.2
Lee, A.W.3
Akei, H.S.4
Brandt, E.B.5
Williams, D.A.6
Cancelas, J.A.7
-
79
-
-
14844300589
-
Identification of FIP1L1-PDGFRA fusion, and expression of signal transducer and activator of transcription 5 in hypereosinophilic syndrome
-
Zhang, G.S., Li, B., Pei, M.F., Dai, C.W., Zheng, W.L. and Shen, J.K. 2004. [Identification of FIP1L1-PDGFRA fusion, and expression of signal transducer and activator of transcription 5 in hypereosinophilic syndrome]. Zhonghua Yi Xue Za Zhi, 84:1541-1544.
-
(2004)
Zhonghua Yi Xue Za Zhi
, vol.84
, pp. 1541-1544
-
-
Zhang, G.S.1
Li, B.2
Pei, M.F.3
Dai, C.W.4
Zheng, W.L.5
Shen, J.K.6
|